Literature DB >> 562883

Familial idiopathic hyperphosphatasia: a study of two young siblings treated with porcine calcitonin.

O Blanco, M Stivel, C Mautalen, F Schajowicz.   

Abstract

A study of two siblings with a severe infantile form of familial idiopathic hyperphosphatasia is reported. A girl aged one year was followed for two years while receiving intermittent treatment with porcine calcitonin. This induced a clinical remission, a reduction of both the high serum level of alkaline phosphatase and the raised urinary excretion of hydroxyproline, and a remarkable improvement in bone structure as seen radiologically. Her sister aged two months received porcine calcitonin for three weeks, during which clinical improvement, no change in the serum level of alkaline phosphatase and a marked decrease of the excretion of hydroxyproline were recorded.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 562883

Source DB:  PubMed          Journal:  J Bone Joint Surg Br        ISSN: 0301-620X


  6 in total

1.  Post-partum hypercalcemia in hereditary hyperphosphatasia (juvenile Paget's disease).

Authors:  N Chosich; F Long; R Wong; D J Topliss; J R Stockigt
Journal:  J Endocrinol Invest       Date:  1991 Jul-Aug       Impact factor: 4.256

2.  Juvenile Paget's disease with heterozygous duplication within TNFRSF11A encoding RANK.

Authors:  Michael P Whyte; Cristina Tau; William H McAlister; Xiafang Zhang; Deborah V Novack; Virginia Preliasco; Eduardo Santini-Araujo; Steven Mumm
Journal:  Bone       Date:  2014-07-23       Impact factor: 4.398

3.  [Osteitis deformans (Paget)--or a tarda-type of a hereditary hyperphosphatasia (author's transl)].

Authors:  A Enderle; S von Gumppenberg
Journal:  Arch Orthop Trauma Surg       Date:  1979-07-31

Review 4.  Craniotubular bone disorders.

Authors:  R J Gorlin
Journal:  Pediatr Radiol       Date:  1994

Review 5.  Genotype-phenotype correlation in juvenile Paget disease: role of molecular alterations of the TNFRSF11B gene.

Authors:  Giacomina Brunetti; Flaviana Marzano; Silvia Colucci; Annamaria Ventura; Luciano Cavallo; Maria Grano; Maria Felicia Faienza
Journal:  Endocrine       Date:  2012-05-26       Impact factor: 3.633

Review 6.  Pharmacology and therapeutic use of calcitonin.

Authors:  J C Stevenson; I M Evans
Journal:  Drugs       Date:  1981-04       Impact factor: 9.546

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.